References
Buchler M, Leibenguth P, Le Guellec C, Carayon A, Watier H, Odoul F, Autret-Leca E, Lebranchu Y, Paintaud G (2004) Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients. Eur J Clin Pharmacol 60:703–708
Zhang W (2002) Old and new tools to dissect calcineurin’s role in pressure-overload cardiac hypertrophy. Cardiovasc Res 53:294–303
Zdrenghea D, Pop D, Bodizs G, Cebanu M, Rusu R, Grosz CS (2003) The acute effect of ACEI and ARB’s upon endothelin in heart failure patients. Rom J Int Med 41:387–393
Schneider JG, Tilly N, Hierl T, Sommer U, Hamann A, Dugi K, Leidig-Bruckner G, Kasperk C (2002) Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens 15:967–972
Bragulat E, Larrousse M, Coca A, de la Sierra A (2003) Effect of long-term irbesartan treatment on endothelium-dependent vasodilation in essential hypertensive patients. Br J Biomed Sci 60:191–196
Trackman PC, Kantarci A (2004) Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 15:165–175
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zehngawa, W. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients—a comment. Eur J Clin Pharmacol 61, 317 (2005). https://doi.org/10.1007/s00228-005-0913-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-005-0913-x